Ukraine’s Biofarma reportedly doubles investment in Romanian plants at EUR 85 mln

30 July 2026 Ukrainian plasma-derived drugs producer Biofarma has doubled its planned investment in a pharmaceutical plant in Oradea, western Romania, with the first stage of the project now valued at EUR 85 million, Bihoreanul reported, cited by Economedia.ro. The investment is EUR 48 million above the minimum amount announced in 2024, when the construction of the pharmaceutical factory was presented as the largest investment of that year in the industrial parks managed by the Oradea Local Development Agency. The Oradea project is planned in four stages, according to Biofarma representatives cited by Interfax-Ukraine. The company has not disclosed the total value of the investment, providing only the cost of bringing the first stage into operation. "We have already completed the construct